| 1055 |
Centers for Disease Control and Prevention |
Html |
en |
Notifiable Diseases and Mortality Tables |
Table I Summary of provisional cases of selected notifiable diseases, United States, cumulative, week ending April 5, 2014 (14th Week). |
| different event codes | 0.547208 |
| H. influenzae | 0.452416 |
| CDC | 0.4145 |
| California serogroup | 0.557173 |
| age group | 0.387852 |
| novel influenza | 0.704755 |
| invasive pneumococcal disease | 0.8938 |
| eastern equine | 0.38025 |
| ** Data | 0.425287 |
| western equine diseases | 0.534149 |
| case notifications | 0.392553 |
| susceptible cases | 0.441506 |
| probable cases | 0.45834 |
| Rocky Mountain | 0.373753 |
| rickettsia infections | 0.426476 |
| ArboNET Surveillance | 0.379965 |
| Zoonotic | 0.241072 |
| rubella cases | 0.454612 |
| Spotted fever rickettsioses | 0.611869 |
| St. Louis | 0.383208 |
| E. coli | 0.385422 |
| influenza A virus | 0.549988 |
| virus infections | 0.44342 |
| National Center | 0.576491 |
|
| Immunization | 0.238769 |
| cases | 0.646473 |
| pneumoniae invasive disease | 0.606121 |
| Table | 0.29462 |
| Total case counts | 0.565316 |
| Spotted fever group | 0.609672 |
| serogroup non-O157 | 0.557032 |
| serotypes | 0.237824 |
| Shiga | 0.291651 |
| similar clinical presentation | 0.533063 |
| Vector-Borne Infectious Diseases | 0.573436 |
| meningococcal disease | 0.401357 |
| Cumulative total E. | 0.562309 |
| measles case | 0.439815 |
| condition | 0.258104 |
| Influenza Division | 0.513616 |
| Streptococcus | 0.243227 |
| unknown serogroup | 0.557755 |
| Respiratory Diseases | 0.402635 |
| Powassan | 0.245796 |
| ages | 0.237856 |
| Enteric Diseases | 0.398333 |
| Includes drug resistant | 0.553267 |
|
CLICK HERE |
| 6076 |
Centers for Disease Control and Prevention |
Html |
en |
Captafol - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6079 |
Centers for Disease Control and Prevention |
Html |
en |
bis(2-(Dimethylamino)ethyl)ether - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 8100 |
Centers for Disease Control and Prevention |
Html |
en |
Air Pollution & Respiratory Health - Recent Branch Publications |
This is the Air Pollution and Respiratory Health home page. |
| adult Asthma Call-back | 0.601429 |
| asthma outcomes | 0.601037 |
| School-Based Asthma Program | 0.579759 |
| Asthma Morbidity | 0.598737 |
| Wisconsin asthma prevalence | 0.602628 |
| Occupational Asthma Incidence | 0.600684 |
| Risk Factor Surveillance | 0.593752 |
| asthma self-management education | 0.629228 |
| Asthma Management | 0.595585 |
| Zahran HS | 0.600073 |
| asthma onset | 0.602122 |
| current asthma | 0.667256 |
| asthma control status | 0.619257 |
| asthma prevention | 0.600892 |
| Public Health Management | 0.606821 |
| Asthma CRC Press | 0.576999 |
| Emergency Department Asthma | 0.601922 |
| Asthma Incidence | 0.600949 |
| carbon monoxide | 0.871289 |
| asthma | 0.916568 |
| asthma control | 0.660504 |
| School-Based Asthma Interventions. | 0.588094 |
| American Journal | 0.79325 |
| Mazurek JM | 0.652591 |
| subsequent asthma outcomes | 0.584784 |
|
| Current Asthma Prevalence | 0.58261 |
| State Asthma Program | 0.627621 |
| Behavioral Risk Factor | 0.595117 |
| Asthma Friendly Schools | 0.597592 |
| United States | 0.901767 |
| Asthma Call-back Survey—United | 0.581472 |
| asthma call-back survey. | 0.699538 |
| Asthma Care | 0.580393 |
| work-related asthma | 0.686346 |
| Moorman JE | 0.838108 |
| Asthma Among Employed | 0.583268 |
| asthma health education | 0.61831 |
| asthma prevalence | 0.787425 |
| public health | 0.827795 |
| health care | 0.580681 |
| Preventive Asthma Medication | 0.578945 |
| Yip FY | 0.726238 |
| School-Based Asthma | 0.594753 |
| Surveillance System Asthma | 0.635712 |
| Allergy Asthma Immunol. | 0.606255 |
| asthma education | 0.620516 |
| carbon monoxide poisoning | 0.818951 |
| Asthma Program Evaluation | 0.591398 |
| asthma symptoms | 0.605713 |
|
CLICK HERE |
| 8684 |
Centers for Disease Control and Prevention |
Html |
en |
National Shortage of Purified-Protein Derivative TuberculinProducts |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| IGRA blood tests | 0.848988 |
| TB exposure | 0.483334 |
| CDC | 0.439692 |
| PPD tuberculin product | 0.491164 |
| original MMWR paper | 0.457918 |
| U.S. Government Printing | 0.453198 |
| TB control officials | 0.586684 |
| normal distribution networks | 0.464721 |
| Human Services | 0.457145 |
| infection control | 0.419155 |
| occupational health | 0.468536 |
| public health authorities | 0.472253 |
| U.S. Department | 0.457233 |
| MMWR HTML versions | 0.451417 |
| TST antigens | 0.468599 |
| TB contact investigations | 0.564817 |
| IGRA result | 0.510943 |
| acid amplification test | 0.47209 |
| occupational health authorities | 0.458174 |
| TST results | 0.48986 |
| commercial IGRA blood | 0.616379 |
| interferon-ЮГ release assay | 0.466194 |
| electronic PDF version | 0.452335 |
| Tubersol | 0.414597 |
|
| TB infection | 0.633622 |
| public health | 0.557195 |
| Tuberculosis Prevention | 0.407591 |
| Mycobacterium tuberculosis infection | 0.522748 |
| routine serial testing | 0.45515 |
| routine serial TSTs | 0.463293 |
| tuberculin products | 0.405767 |
| IGRA blood test | 0.955203 |
| ) disease. | 0.584123 |
| tuberculin skin tests | 0.505396 |
| Sanofi Pasteur Limited | 0.498133 |
| Substitute IGRA blood | 0.617188 |
| public health officials | 0.483387 |
| positive TST | 0.474785 |
| blood specimens | 0.413727 |
| Tubersol supplies | 0.409695 |
| negative TST | 0.472027 |
| specific laboratory services | 0.460582 |
| John Jereb | 0.444801 |
| Aplisol | 0.409721 |
| Acute local shortages | 0.502659 |
| original paper copy | 0.445807 |
| previous Bacille Calmette-GuУЉrin | 0.45818 |
|
CLICK HERE |
| 9084 |
Centers for Disease Control and Prevention |
Html |
en |
Cholera | Antibiotic Treatment |
Recommendations for the Use of Antibiotics for the Treatment of Cholera |
| Optimal antibiotic therapy | 0.584856 |
| actively purging cholera | 0.715261 |
| epidemic cholera | 0.772695 |
| doxycycline | 0.566601 |
| randomized controlled trials | 0.566007 |
| pregnant women | 0.584915 |
| WHO. Cholera Outbreak | 0.716548 |
| Salam MA | 0.568414 |
| antibiotic prophylaxis | 0.579029 |
| first-line treatment | 0.578701 |
| epidemic cholera settings | 0.73728 |
| cholera mortality | 0.712953 |
| antibiotic treatment | 0.657417 |
| childhood cholera | 0.680995 |
| cholera patients | 0.800892 |
| cholera epidemic | 0.727414 |
| Clin Infect Dis. | 0.58939 |
| Antibiotic choices | 0.573408 |
| World Health Organ. | 0.708934 |
| cholera responses | 0.700859 |
| Khan WA | 0.591438 |
| Antimicrob Agents Ch. | 0.599034 |
| household contacts | 0.573522 |
| Cholera Guidelines | 0.688138 |
| antibiotics | 0.657981 |
|
| rehydration treatment | 0.569065 |
| hydration treatment | 0.574268 |
| treatment guidance documents | 0.57375 |
| antibiotic therapy | 0.588357 |
| Trop Med H. | 0.601779 |
| Vibrio cholerae | 0.589901 |
| local antibiotic susceptibility | 0.605767 |
| severely ill patients | 0.624135 |
| cholera prevention | 0.754136 |
| cholera morbidity | 0.708687 |
| Antibiotic regimens | 0.569982 |
| A. The cholera | 0.696341 |
| antibiotic resistance | 0.616559 |
| Over-emphasizing antibiotics | 0.58795 |
| cholera | 0.908688 |
| azithromycin versus ciprofloxacin | 0.576384 |
| Soc Trop Med | 0.602143 |
| MR. Antibiotic therapy | 0.587596 |
| aggressive hydration | 0.574231 |
| cholera treatment | 0.791108 |
| Cholera Outbreak Training | 0.715139 |
| Bennish ML | 0.571338 |
| blue epidemic cholera | 0.728701 |
| Antibiotic Treatment Guidelines | 0.619902 |
|
CLICK HERE |
| 9106 |
Centers for Disease Control and Prevention |
Html |
en |
Office of the Associate Director for Communication (OADC) | CDC |
CDC.gov Web Metrics Dashboard. Key performance indicators and data for CDC’s Web site, Social Media, and Campaigns. CDC is sharing this data as part of the agency’s commitment to transparent government. |
| safety threats | 0.719184 |
| CDC’s communication | 0.769586 |
| work | 0.449829 |
| organizational goals | 0.672155 |
| health | 0.449523 |
| Page | 0.444227 |
| office | 0.491106 |
| Associate Director | 0.976936 |
| PhD | 0.45405 |
|
| home | 0.448973 |
| success measures | 0.669193 |
| –Katherine Lyon Daniel | 0.870055 |
| PDF | 0.445195 |
| OADC | 0.487642 |
| KB | 0.578294 |
| America | 0.449645 |
| principles | 0.444569 |
| 24/7 | 0.44989 |
|
CLICK HERE |
| 12740 |
Centers for Disease Control and Prevention |
Html |
en |
Advisory Committee on Immunization Practices RecommendedImmunization Schedule for Adults Aged 19 Years or Older - UnitedStates, 2015 |
David K. Kim, MD1, Carolyn B. Bridges, MD1, Kathleen H. |
| agency guidelines | 0.304435 |
| CDC Director | 0.306316 |
| Mortality Weekly Report | 0.476105 |
| American Academy | 0.430936 |
| United States | 0.564322 |
| precautions | 0.20514 |
| Drug Administration | 0.326476 |
| routine administration | 0.386961 |
| expert external advice | 0.495208 |
| commonly used vaccines | 0.659095 |
| greatest extent | 0.312863 |
| federal advisory committee | 0.491642 |
| related agents | 0.317997 |
| Immunization Practices | 0.637959 |
| Disease Control | 0.313023 |
| Gynecologists | 0.215657 |
|
| Obstetricians | 0.213551 |
| advisory committee | 0.792411 |
| American College | 0.98748 |
| Family Physicians | 0.508998 |
| civilian population | 0.312238 |
| pneumococcal conjugate vaccine | 0.619538 |
| primary contraindications | 0.359146 |
| ACOG | 0.226133 |
| Additional information | 0.313996 |
| recombinant influenza vaccine | 0.619746 |
| ACIP recommendations | 0.834728 |
| AAFP | 0.207387 |
| Adults Aged | 0.383422 |
| adult immunization schedule | 0.607542 |
| Recommended Immunization Schedule | 0.648793 |
| vaccine-preventable diseases | 0.336045 |
|
CLICK HERE |
| 12947 |
Centers for Disease Control and Prevention |
Html |
en |
Community Health Status Indicators Website Launch |
Today, CDC released the updated Community Health Status Indicators (CHSI) online tool that produces public health profiles for all 3,143 counties in the United States. |
| United States | 0.641223 |
| re-designed online application | 0.728598 |
| health status indicators | 0.950141 |
| CHSI data | 0.621968 |
| U.S. Census tract | 0.739465 |
| health outcomes | 0.733589 |
| Community Health Status | 0.792398 |
| physical environment | 0.627254 |
| U.S. DEPARTMENT | 0.619659 |
| population health status | 0.766635 |
| summary comparison page | 0.726426 |
| Healthy People | 0.618862 |
| health behaviors | 0.659399 |
| visit http://wwwn.cdc.gov/communityhealth | 0.615862 |
| health care access | 0.760525 |
|
| peer counties | 0.635671 |
| peer county groups | 0.742009 |
| social factors | 0.638863 |
| community health assessments | 0.740156 |
| age groups | 0.621347 |
| potential health disparities. | 0.74542 |
| quality | 0.520063 |
| new version | 0.620605 |
| U.S. counties | 0.622648 |
| public health profiles | 0.788718 |
| median | 0.536906 |
| online tool | 0.641807 |
| HUMAN SERVICES | 0.617402 |
| targets. Organizations | 0.618364 |
|
CLICK HERE |
| 15992 |
Centers for Disease Control and Prevention |
Html |
en |
Training |
Information on Zika virus. Provided by the U.S. Centers for Disease Control and Prevention. |
| Reagents | 0.549136 |
| Titration | 0.429163 |
| Instructions | 0.235017 |
|
| information | 0.23435 |
| Supplies | 0.233683 |
|
CLICK HERE |